Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

by Punnee Pitisuttithum, Supachai Rerks-Ngarm, Valai Bussaratid, Jittima Dhitavat, Wirach Maekanantawat, Swangjai Pungpak, Pravan Suntharasamai, Sirivan Vanijanonta, Sorachai Nitayapan, Jaranit Kaewkungwal, Michael Benenson, Patricia Morgan, Robert J O'Connell, Jeffrey Berenberg, Sanjay Gurunathan, Donald P Francis, Robert Paris, Joseph Chiu, Donald Stablein, Nelson L Michael, Jean-Louis Excler, Merlin L Robb, Jerome H Kim
Published 2011-01-01